Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with early-stage primary breast cancer
- Women between the ages of 18 and 60 years old (including those aged exactly 18 or 60)
- People whose breast cancer is hormone receptor (HR) positive and HER2 negative (these are specific characteristics of the cancer cells, confirmed by testing)
- People who have received 5 years of ovarian function suppression (OFS) treatment, which is a therapy that reduces the hormones produced by the ovaries
- People with an ECOG performance score of 0 or 1, meaning they are either fully active or have only minor restrictions in physical activity (confirm with trial site)
- People who are willing to participate voluntarily and sign a consent form
- People whose treating doctor believes they may benefit from joining the trial
Who may not be able to join:
- People who are currently receiving other treatments that interfere with ovarian function suppression (OFS) therapy, or who have received OFS treatment for less than 5 years
- People with known and clearly symptomatic cancer spread to the brain or central nervous system, such as headaches, brain swelling, or blurred vision
- People with known and clearly symptomatic cancer that has spread to other parts of the body (invasive metastases) (confirm with trial site for full details)
- People whose treating doctor considers the trial to be unsuitable for them
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hongmei Zheng, Doctor, Study Principal Investigator
Phone: 18971624606
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
invasive disease-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.